mdxhealth announced its Q3 2026 financial results with revenue steady at $22.7 million compared to last year, but operating loss increased to $8.1 million due to higher expenses from the ExoDx acquisition. The company is restructuring its commercial team to improve sales execution after turnover issues and expects to rebuild its sales force by Q4 to return to growth in 2027. Despite a 26% rise in net loss to $12.3 million, mdxhealth remains focused on advancing its prostate cancer diagnostics and strategic AI initiatives.
Mdxhealth's Q3 2026 financial results provide context for health sector activity. For readers following health stocks, here is Pluang's market snapshot as of Nov 13, 2026 04:11 WIB: Out of 150 priced health-sector US stocks, 23 rose and 124 fell. Notable movers include IBRX at USD 6.06 with a -9.15% change and 98% sell order activity, BNGO at USD 1.00 down 9.09%, and FLNA at USD 0.44 down 8.71% with 87% buy order activity.
Siemens reported earnings per share of $1.62 and revenue of $26.28 billion, both exceeding analyst expectations. The company saw record orders and double-digit revenue growth in its smart infrastructure and digital industries units, prompting it to r...
ASUS has introduced a broad ecosystem of AI-ready hardware and software designed for gamers, creators, developers, and enterprises. The ASUS Agent Computer initiative enables users to deploy AI locally, in the cloud, or via hybrid models, offering co...
The global cosmetic peptide synthesis market is projected to grow from $274 million in 2027 to $354.85 million by 2032, with a CAGR of 5.34%. Growth is fueled by rising demand for advanced anti-aging skincare ingredients, increased use of peptide-bas...
Cisco is set to report its fiscal Q1 2027 earnings with a focus on cloud growth and AI demand. Analysts expect revenue around $18.1 billion, operating income of $6.5 billion, and earnings per share of $1.33, reflecting strong year-over-year growth. T...
BASF has agreed to sell its global mining solutions business to SNF, a specialty chemical company based in France, following a strategic review of BASF's Performance Chemicals division. The deal includes BASF's mining chemicals portfolio, production ...
